Fact CheckerSign in

NCT06771427Recruiting

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

Systemic Proteomic Analysis of Plasma Exosomes to Explore the Immunomodulation Reflected to Sjogren's Syndrome and Dry Eye Syndrome

Source: ClinicalTrials.gov · Last updated 17 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.

Status (registry)
Recruiting
Study type
Observational
Enrollment
220 (estimated)
First submitted
8 Jan 2025
Start date
16 Jan 2025
Primary completion date
30 Apr 2025
Lead sponsor
Taipei Veterans General Hospital, Taiwan
NCT number
NCT06771427

What you commit to

  • Study type: Observational
  • Planned participants: 220
  • From 16 Jan 2025 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • non AIDDES Healthy Controls

Criteria the registry did not label

  • Dry eye syndrome

Age in the registry: 20 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ching-Mao
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.